| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.29B | 12.51B | 12.99B | 10.02B | 7.31B | 5.31B |
| Gross Profit | 5.74B | 4.79B | 7.08B | 3.40B | 2.93B | 2.27B |
| EBITDA | 3.43B | 3.26B | 2.65B | 895.80M | 4.84B | 881.80M |
| Net Income | 1.72B | 1.21B | 1.00B | 646.80M | 4.27B | 622.80M |
Balance Sheet | ||||||
| Total Assets | 27.48B | 27.34B | 26.34B | 26.71B | 22.62B | 20.27B |
| Cash, Cash Equivalents and Short-Term Investments | 4.04B | 4.32B | 4.77B | 5.69B | 6.69B | 1.62B |
| Total Debt | 4.80B | 4.83B | 4.84B | 6.22B | 4.80B | 4.12B |
| Total Liabilities | 10.43B | 10.43B | 10.47B | 11.48B | 7.82B | 9.67B |
| Stockholders Equity | 15.06B | 14.78B | 13.68B | 13.01B | 12.43B | 8.01B |
Cash Flow | ||||||
| Free Cash Flow | 1.17B | 1.22B | 1.26B | 505.00M | 665.00M | 966.30M |
| Operating Cash Flow | 2.58B | 2.62B | 2.41B | 1.44B | 1.49B | 1.94B |
| Investing Cash Flow | -2.66B | -1.88B | 31.00M | -2.03B | -749.90M | -1.24B |
| Financing Cash Flow | -13.90M | -818.50M | -1.84B | 395.20M | -73.50M | -815.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | €12.27B | 7.12 | 11.85% | 2.13% | 2.01% | 79.48% | |
68 Neutral | €15.46B | 12.78 | 6.47% | 5.88% | -15.54% | 10.53% | |
68 Neutral | €14.72B | 19.52 | ― | 3.23% | 20.37% | 54.24% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | €22.00B | 9.70 | 9.85% | 4.85% | -12.70% | -12.34% | |
66 Neutral | €11.80B | 10.92 | 12.65% | 5.67% | 16.35% | 67.44% | |
63 Neutral | €10.35B | 7.89 | 14.93% | 5.82% | -6.64% | ― |